As of April 2024 AstraZeneca has a market cap of $211.94 Billion. This makes AstraZeneca the world's 51th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $211.94 B | 1.52% |
2023 | $208.77 B | -0.77% |
2022 | $210.38 B | 15.94% |
2021 | $181.46 B | 38.54% |
2020 | $130.98 B | 0.09% |
2019 | $130.87 B | 38.6% |
2018 | $94.42 B | 8.37% |
2017 | $87.12 B | 26.34% |
2016 | $68.96 B | -20.23% |
2015 | $86.45 B | -3.47% |
2014 | $89.56 B | 20.86% |
2013 | $74.10 B | 26.41% |
2012 | $58.62 B | -2.01% |
2011 | $59.82 B | -8.08% |
2010 | $65.08 B | -4.44% |
2009 | $68.10 B | 14.68% |
2008 | $59.39 B | -4.81% |
2007 | $62.38 B | -23.95% |
2006 | $82.03 B | 5.1% |
2005 | $78.05 B | 30.47% |
2004 | $59.82 B | -26.96% |
2003 | $81.90 B | 35.82% |
2002 | $60.30 B | -25.85% |
2001 | $81.33 B |
On Apr 18th, 2024 the market cap of AstraZeneca was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $351.20 B | 65.70% | ๐บ๐ธ USA |
Novartis NVS | $189.21 B | -10.72% | ๐จ๐ญ Switzerland |
Pfizer PFE | $143.77 B | -32.17% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $182.66 B | -13.82% | ๐บ๐ธ USA |
Eli Lilly LLY | $709.22 B | 234.62% | ๐บ๐ธ USA |
Sanofi SNY | $113.31 B | -46.54% | ๐ซ๐ท France |
Biogen BIIB | $27.69 B | -86.93% | ๐บ๐ธ USA |
Merck MRK | $317.21 B | 49.67% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $97.89 B | -53.81% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $81.21 B | -61.68% | ๐ฌ๐ง UK |